Skip Nav Destination
Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients
A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis
Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase
The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype
Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection
Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation
Issue Archive
Table of Contents
INSIDE BLOOD
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients
Clinical Trials & Observations
Karim Belhadj,Félix Reyes,Jean-Pierre Farcet,Hervé Tilly,Christian Bastard,Régis Angonin,Eric Deconinck,Frédéric Charlotte,Véronique Leblond,Eric Labouyrie,Pierre Lederlin,Jean-François Emile,Béatrice Delmas-Marsalet,Bertrand Arnulf,Elie-Serge Zafrani,Philippe Gaulard
A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia
Clinical Trials & Observations
William J. Kell,Alan K. Burnett,Raj Chopra,John A. L. Yin,Richard E. Clark,Ama Rohatiner,Dominic Culligan,Ann Hunter,Archie G. Prentice,Donald W. Milligan
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma
Clinical Trials & Observations
Hervé Tilly,Eric Lepage,Bertrand Coiffier,Michel Blanc,Raoul Herbrecht,André Bosly,Michel Attal,Georges Fillet,Catherine Guettier,Thierry Jo Molina,Christian Gisselbrecht,Félix Reyes,for the Groupe d'Etude des Lymphomes de l'Adulte
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis
Clinical Trials & Observations
Gerard Michel,Vanderson Rocha,Sylvie Chevret,William Arcese,Kah-Wah Chan,Alexandra Filipovich,Tsuneo A. Takahashi,Marcus Vowels,Juan Ortega,Pierre Bordigoni,Peter J. Shaw,Isaac Yaniv,Alexandra Machado,Pedro Pimentel,Franca Fagioli,Amparo Verdeguer,Jean Pierre Jouet,Blanca Diez,Euripedes Ferreira,Ricardo Pasquini,Joseph Rosenthal,Eric Sievers,Chiara Messina,Anna Paola Iori,Federico Garnier,Irina Ionescu,Franco Locatelli,Eliane Gluckman,for the Eurocord Group
Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase
Clinical Trials & Observations
Martine Gardembas,Philippe Rousselot,Michel Tulliez,Magda Vigier,Agnès Buzyn,Françoise Rigal-Huguet,Laurence Legros,Mauricette Michallet,Christian Berthou,Nathalie Cheron,Frederic Maloisel,François-Xavier Mahon,Thierry Facon,Patrice Berthaud,Joëlle Guilhot,François Guilhot,for the CML French Group (FIϕLMC)
GENE THERAPY
HEMATOPOIESIS
Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model
Françoise Norol,Pascal Merlet,Richard Isnard,Pascale Sebillon,Nicolas Bonnet,Christian Cailliot,Claire Carrion,Maria Ribeiro,Frédéric Charlotte,Pascal Pradeau,Jean-François Mayol,André Peinnequin,Michel Drouet,Karima Safsafi,Jean-Paul Vernant,Francis Herodin
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogs
Karen E. Russell,Eva H. N. Olsen,Robin A. Raymer,Elizabeth P. Merricks,Dwight A. Bellinger,Marjorie S. Read,Bonita J. Rup,James C. Keith, Jr,Kyle P. McCarthy,Robert G. Schaub,Timothy C. Nichols
IMMUNOBIOLOGY
NEOPLASIA
The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype
Clinical Trials & Observations
Daniel Steinbach,Susann Wittig,Gunnar Cario,Susanne Viehmann,Angelika Mueller,Bernd Gruhn,Ralf Haefer,Felix Zintl,Axel Sauerbrey
Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis
Faith E. Davies,Ann M. Dring,Cheng Li,Andrew C. Rawstron,Masood A. Shammas,Sheila M. O'Connor,James A.L. Fenton,Teru Hideshima,Dharminder Chauhan,Isabella T. Tai,Elizabeth Robinson,Daniel Auclair,Karen Rees,David Gonzalez,A. John Ashcroft,Ranjit Dasgupta,Constantine Mitsiades,Nicholas Mitsiades,Lan B. Chen,Wing H. Wong,Nikhil C. Munshi,Gareth J. Morgan,Kenneth C. Anderson
Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection
Clinical Trials & Observations
Aihong Li,Jianbiao Zhou,David Zuckerman,Montse Rue,Virginia Dalton,Cheryl Lyons,Lewis B. Silverman,Stephen E. Sallan,John G. Gribben
RED CELLS
Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation
Clinical Trials & Observations
Hermann Heimpel,Volker Anselstetter,Ladislav Chrobak,Jonas Denecke,Beate Einsiedler,Kerstin Gallmeier,Antje Griesshammer,Thorsten Marquardt,Gritta Janka-Schaub,Martina Kron,Elisabeth Kohne
TRANSFUSION MEDICINE
TRANSPLANTATION
Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease
Jean-François Poulin,Myriam Sylvestre,Patrick Champagne,Marie-Lise Dion,Nadia Kettaf,Alain Dumont,Maryse Lainesse,Pierre Fontaine,Denis-Claude Roy,Claude Perreault,Rafick-Pierre Sékaly,Rémi Cheynier
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals